Your Guide to Financial Freedom
Advanced Micro Devices (NASDAQ: AMD) delivered a textbook “beat-and-raise” quarter for fiscal Q2 2026, yet investors punished the stock with a 7% sell-off the following session. The Santa Clara-based semiconductor giant reported revenue of $11.54 billion, representing 50.1% year-over-year growth, while adjusted earnings per share surged 246% to $1.66. Despite clearing Wall Street estimates on … Read more
SanDisk Delivers Historic Quarter but Guidance Disappoints On August 5, SanDisk (NASDAQ: SNDK) reported what management called the best quarter in company history. Revenue surged 372% year-over-year to $8.97 billion, gross margin hit a record 84.6%, and both top- and bottom-line results exceeded Wall Street consensus estimates. The company also authorized an additional $14 billion … Read more
South Korea’s Market Crash Exposes Dangers of Leveraged ETFs South Korea’s benchmark KOSPI index cratered 44% from its June peak — a collapse worse than the 2020 pandemic crash — before staging a record-breaking 18% single-day rebound on Friday. The violent round-trip wasn’t driven solely by macro fears over AI capital expenditure or tech debt. … Read more
As artificial intelligence reshapes the technology landscape, investors face a classic dilemma: bet on the software giant powering global creativity or the infrastructure player building the high-speed highways that make AI possible. Adobe (NASDAQ: ADBE) and Arista Networks (NYSE: ANET) represent two distinct paths to AI exposure—one through mission-critical creative and marketing software, the other … Read more
Memory Chip Giants Flash Warning on Pricing Momentum Recent quarterly results from SK Hynix (NASDAQ: SKHY) and Samsung Electronics (OTC: SSNLF) have delivered a sobering message for Micron Technology (NASDAQ: MU) shareholders: the memory chip upcycle may be peaking earlier and at lower levels than Wall Street anticipated. All three companies dominate the global DRAM … Read more
Medtronic plc (NYSE: MDT) is capturing Wall Street’s attention after UBS upgraded the medical device giant to a Buy rating from Neutral, citing a credible turnaround underway. The upgrade arrives on the heels of the company’s strongest annual revenue growth in a decade, prompting investors to reassess whether the Dublin-headquartered conglomerate has finally broken out … Read more
UnitedHealth Doubles Down on Community Care Amid Turnaround UnitedHealth Group (NYSE: UNH) announced a $4 million commitment through the United Health Foundation to expand the University of Tennessee Health Science Center’s health hub network from five to 13 locations across the state by the end of 2027. The initiative aims to reach 200,000 Tennessee residents, … Read more
The Retirement Income Bridge: $3,500 Monthly From Two Funds A 61-year-old investor facing the pre-Social Security gap needs roughly $42,000 annually to cover housing, healthcare premiums, and living expenses. This “bridge number” is a common retirement planning challenge. Two exchange-traded funds (ETFs) — Schwab U.S. Dividend Equity ETF (SCHD) and JPMorgan Nasdaq Equity Premium Income … Read more
Berkshire’s Operating Earnings Rise 16%, But Currency Swings Drive Most of the Gain Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B) reported second-quarter operating earnings of $12.98 billion, a 16% increase from $11.16 billion a year earlier. While the headline figure looks impressive, a closer look reveals that approximately $1.2 billion of the $1.8 billion total increase stemmed … Read more
Eli Lilly (LLY) delivered a second-quarter performance robust enough to shift the narrative surrounding its stock. For months, investors fixated on a sluggish U.S. launch for its new oral obesity pill, Foundayo. That concern hasn’t vanished, but Bank of America analysts argue it’s no longer the dominant driver. Instead, BofA points to a massive, underappreciated … Read more